Log In
Print
BCIQ
Print
Print this Print this
 

Tetrabik (BK-4SP)

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSubcutaneous vaccine comprises Bordetella pertussis, diphtheria toxoid, tetanus toxoid and inactivated Savin types 1, 2 and 3 of polio virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard Indication Infectious (unspecified)
Indication DetailsVaccinate against diphtheria, pertussis, tetanus and poliomyelitis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today